FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099341 [Registered on: 17/12/2025] Trial Registered Prospectively
Last Modified On: 14/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Biological
Other (Specify) [PLATLET RICH PLASMA]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Platelet Rich Plasma for endometrial regeneration in infertile women  
Scientific Title of Study   Comparison of the effect of Intrauterine Platelet Rich Plasma instillation to oestradiol valerate alone in infertile women with thin endometrium undergoing Ovarian Stimulation: An Open Labelled Randomised Control Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Divya leela Kayala 
Designation  junior resident 
Affiliation  AIIMS PATNA 
Address  Room no 237 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Room no 237 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Patna
BIHAR
801507
India 
Phone  9505073759  
Fax    
Email  divya14146@aiimspatna.org  
 
Details of Contact Person
Scientific Query
 
Name  Divya leela Kayala 
Designation  junior resident 
Affiliation  AIIMS PATNA 
Address  Room no 237 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Room no 237 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Patna
BIHAR
801507
India 
Phone  9505073759  
Fax    
Email  divya14146@aiimspatna.org  
 
Details of Contact Person
Public Query
 
Name  Indira Prasad 
Designation  Additional professor 
Affiliation  AIIMS PATNA 
Address  Room no 242 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Room no 242 ,Department of Obstetrics and Gynecology,OPD building,AIIMS,Patna, Phulwarisharif,Patna,Bihar,801507
Patna
BIHAR
801507
India 
Phone  8860033085  
Fax    
Email  drindirap@aiimspatna.org  
 
Source of Monetary or Material Support  
AIIMS PATNA  
 
Primary Sponsor  
Name  AIIMS PATNA 
Address  Aiims patna pulwarisharif patna bihar 801507 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
AIIMS PATNA  Aiims patna pulwarisharif patna bihar 801507 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Divya Leela Kayala  AIIMS PATNA   room no 242, obstetrics and gynecology department, OPD building Aiims patna pulwarisharif patna bihar 801507
Patna
BIHAR 
9505073759

divya14146@aiimspatna.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Comittee, AIIMS PATNA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O94-O9A||Other obstetric conditions, not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  estradiol valerate  giving estradiol valerate in infertle women with thin endometrium 
Intervention  PRP instillation   3ml of PRP instillation intrauterine using intrauterine catheter once over 10 mins in addition to estradiol valerate in infertile women with thin endometrium 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  infertile women aged 20 to 40 years with endometrial thickness of less than 7mm
platelets greater than 1,50,000 
 
ExclusionCriteria 
Details  NSAID intake 3 days before procedure
patient on anticoagulation therapy
severe male infertility factor
tubal factors
mullerian anomalies
asherman syndrome
moderate to severe endometriosis
platelet count less than 1,50,000
diseases such as hepatitis B,hepatitis C,syphilis,HIV
active vaginal or cervical infections
pelvic inflammatory disease 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
increase in endometrial thickness and endometrial vascularity   48 hr 
 
Secondary Outcome  
Outcome  TimePoints 
biochemical pregnancy rate
clinical pregnancy rate
live birth rate 
1 month
2 months
12 months 
 
Target Sample Size   Total Sample Size="56"
Sample Size from India="56" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   29/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Thin endometrium is a significant barrier to successful implantation in infertile women undergoing ovarian stimulation. Endometrial thickness (ET) less than 7 mm is associated with reduced pregnancy rates. Conventional treatment includes estradiol valerate; however, recent studies suggest intrauterine Platelet Rich Plasma (PRP) may enhance endometrial growth and vascularity. This open-labelled randomized controlled trial aims to compare the effects of PRP instillation combined with estradiol valerate versus estradiol valerate alone in infertile women with thin endometrium. The primary objective is to assess changes in ET and endometrial vascularity, while secondary outcomes include pregnancy and live birth rates. The study involves 56 participants randomized into two groups, with pre- and post-intervention ultrasound assessments. If effective, PRP could become a recommended adjunct in thin endometrium management. 
Close